THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;GENZYME CORPORATION
发明人:
WADSWORTH, SAMUEL,SCARIA, ABRAHAM,CHAN, CHI-CHAO
申请号：
CA2909706
公开号：
CA2909706A1
申请日:
2014.04.17
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
Compositions and methods for treating macular degeneration are disclosed. The methods utilize IL17 inhibitors, such as IL17 receptors, as well as fusion proteins including an IL17 receptor fused with a multimerization domain, and recombinant viral vectors encoding such fusions.
